- Home
- URG vs AQST Comparison
URG vs AQST Comparison
Compare URG & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- AQST
- Stock Information
- Founded
- URG 2004
- AQST 2004
- Country
- URG United States
- AQST United States
- Employees
- URG N/A
- AQST N/A
- Industry
- URG Precious Metals
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- URG Basic Materials
- AQST Health Care
- Exchange
- URG Nasdaq
- AQST Nasdaq
- Market Cap
- URG 458.8M
- AQST 502.6M
- IPO Year
- URG N/A
- AQST 2018
- Fundamental
- Price
- URG $1.13
- AQST $3.65
- Analyst Decision
- URG Strong Buy
- AQST Strong Buy
- Analyst Count
- URG 2
- AQST 8
- Target Price
- URG $2.45
- AQST $10.38
- AVG Volume (30 Days)
- URG 3.9M
- AQST 1.7M
- Earning Date
- URG 11-06-2024
- AQST 11-04-2024
- Dividend Yield
- URG N/A
- AQST N/A
- EPS Growth
- URG N/A
- AQST N/A
- EPS
- URG N/A
- AQST N/A
- Revenue
- URG $16,494,000.00
- AQST $58,900,000.00
- Revenue This Year
- URG $86.92
- AQST $18.45
- Revenue Next Year
- URG $73.30
- AQST N/A
- P/E Ratio
- URG N/A
- AQST N/A
- Revenue Growth
- URG 34.78
- AQST 22.56
- 52 Week Low
- URG $0.96
- AQST $1.86
- 52 Week High
- URG $2.01
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- URG 38.27
- AQST 36.47
- Support Level
- URG $1.10
- AQST $3.38
- Resistance Level
- URG $1.29
- AQST $3.92
- Average True Range (ATR)
- URG 0.07
- AQST 0.24
- MACD
- URG -0.02
- AQST -0.04
- Stochastic Oscillator
- URG 17.39
- AQST 19.01
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.